Innostem™, cardistem™ and cardiovastem™ are trademarks of Pharmahungary.
Pharmahungary, a global preclinical and clinical CRO runs some in-house innovative R&D projects for the diagnosis and therapy of cardiovascular and metabolic diseases, currently focusing e.g. on the development of stem cell technology for cardiovascular research and development.
